Navigation Links
Erchonia’s NEW FX 635 Laser for Chronic Low Back Pain will be Available at The National 2018
Date:8/15/2018

The Florida Chiropractic Association’s National Meeting on August 16th-19th in Orlando, FL will be the NEW FX 635 Laser’s unveiling. Doctors from around the U.S. will gain firsthand insights into the new laser’s advancements and superior treatment abilities.

With the NEW FX 635, Erchonia Corporation completed another successful clinical trial that has resulted in the granting of an FDA 510(k) market clearance for chronic low back pain of musculoskeletal origin. This grants another first for Erchonia, which started the low-level laser category in January 2002. That year, the FDA issued its first 510(k) market clearance for any low-level laser based on Erchonia’s clinical trial for chronic neck and shoulder pain.

This new indication for chronic low back pain is the only laser to be market cleared by the FDA. Erchonia’s long history and dedication to the science of low-level laser therapy has led to 15 FDA 510(k) market clearances based on their patented lasers.

About the study: Erchonia through the pre-IDE process worked with the U.S. FDA on study design and success criteria. The success criteria were defined as a minimum of a 30% decrease in chronic low back pain and 35% of patients in the treated group would experience the minimum pain reduction compared to the placebo group. Overall, 72% of patients met the success criteria. Steven Shanks, President of Erchonia stated, “We believe we have demonstrated that the use of non-thermal lasers has proven to be a far better option for treating low back pain than that of opioids or NSAIDS.”

A recent study published in JAMA in 2018 titled "The Space Randomized Clinical Trial" looked at chronic low back pain with opioids and NSAIDS over 1 year. Opioids demonstrated a 30% reduction in pain and NSAIDS proved a 34.5% reduction in pain. The publication concluded that “Results do not support initiation of opioid therapy for moderate to severe back pain or hip or knee osteo arthritis pain”.

Taking into consideration the minimal effectiveness (30%) and the opioid crisis along with the side effects of NSAIDS for chronic low back pain, doctors and patients may now have safer, more effective option for chronic low back pain of musculoskeletal origin that has been proven successful with no side effects or adverse events.

Erchonia would like to thank Doctors Greg Roche, Trevor Berry and Paul Quarneri for their dedication to the science of low-level laser therapy and for helping them document this placebo-controlled, randomized, double-blind, parallel group, multi-center clinical study.

For more information, please visit http://www.erchonia.com.

About Erchonia

A small family company is changing the world with the most advanced non-invasive lasers on the market. Erchonia went from starting in a small garage in 1996 to selling their product in over 50 different countries around the world in 2018. Erchonia has been passionate about researching and developing low level lasers since the beginning with over (15) FDA clearances for treating chronic pain and promoting fat loss. As this family has grown so has the world of non-invasive drug-free healthcare solutions.

Read the full story at https://www.prweb.com/releases/erchonias_new_fx_635_laser_for_chronic_low_back_pain_will_be_available_at_the_national_2018/prweb15694383.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related biology news :

1. Improved material for laser welding of tissue in intestinal surgery
2. CLEO: 2013 -- the Premier International Laser and Electro-Optics Event in San Jose next week
3. CLEO: 2013 press luncheon spotlights new techniques in optofluidics, temporal cloaking, cryolasers
4. LaserLock Technologies Moves Forward With An Even More Secure Multi-Factor Internet/Mobile Login System
5. LaserLock Technologies Files A New Provisional Patent Which Secures Player Identity On Internet Gaming Platforms
6. Information conveyed to urologists regarding laser fiber diameter is incorrect, says new study
7. Laser technology sorting method can improve Capsicum pepper seed quality
8. Lasers offer an automated way to test drinking water
9. Lasers might be the cure for brain diseases such as Alzheimers and Parkinsons
10. Scientists prove X-ray laser can solve protein structures from scratch
11. Fighting cancer with lasers and nanoballoons that pop
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2019)... STATION, Texas (PRWEB) , ... March 29, 2019 ... ... prefabricated, flexible cleanroom solutions, for its new multi-product cell therapy facility. The new ... expand GenCure’s manufacturing capabilities, providing new state of the art manufacturing capabilities to ...
(Date:3/25/2019)... ... March 25, 2019 , ... ... of clinical and research genetic testing, today announced a new laboratory services agreement ... precision medicine for cancer. Through this laboratory services agreement, Ambry Genetics and ...
(Date:3/19/2019)... ... March 19, 2019 , ... Nativis, Inc., today ... The name change is effective immediately for the clinical stage, therapeutic device company, ... In making the announcement, Chris Rivera, Chief Executive Officer, said, “the renaming of ...
Breaking Biology News(10 mins):
(Date:4/10/2019)... ... April 10, 2019 , ... After more than three months ... new kitchen is equipped with updated appliances and modern lighting and fixtures, and will ... , “We’ve seen tremendous growth in the demand for our team-building events ...
(Date:4/8/2019)... and BOSTON (PRWEB) , ... April 08, 2019 ... ... cloud-based enterprise-class unified communications and collaboration solutions, announced today the launch of their ... to an unprecedented range of business and contact-orientated applications while using CT Cloud ...
(Date:4/4/2019)... ... , ... LeadingBiotech, an exclusive event series bringing biopharma CEOs ... CEO conference to be held May 28-29, 2019 at Boston’s Four Seasons Hotel. ... and discussions from past, present and future change-makers. , LeadingBiotech, formerly ...
(Date:3/27/2019)... ... March 27, 2019 , ... Lachman is sponsoring the event on April 1-4, ... Dublin, Ireland. The executive team on site will be available to discuss strategies and ... the agenda this year. , Executives from Lachman participating at this year’s conference include ...
Breaking Biology Technology: